(Q39490174)

12 September 2017

title

Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population-based sample (English)

1 reference

12 September 2017

1

Schunkert H

1 reference

12 September 2017

Hense HW

2

1 reference

12 September 2017

Bröckel U

3

1 reference

12 September 2017

Luchner A

4

1 reference

12 September 2017

Muscholl M

5

1 reference

12 September 2017

Holmer SR

6

1 reference

12 September 2017

Danser AH

7

1 reference

12 September 2017

Mayer B

8

1 reference

12 September 2017

Riegger GA

9

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

Journal of Internal Medicine

12 September 2017

published in

1 reference

12 September 2017

volume

244

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

109-119

1 reference

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Neurohormonal consequences of diuretics in different cardiovascular syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Effect of a calcium entry blocker on blood pressure, plasma renin activity, aldosterone and catecholamines in normotensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Natriuretic effect of calcium-channel blockers in hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Activation of neurohumoral systems in postinfarction left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Control of renin release: A review of experimental evidence and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Angiotensin-converting enzyme inhibitor and spironolactone combination therapy. New objectives in congestive heart failure treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

Effect of aging on plasma renin and aldosterone in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00321.X

10.1046/J.1365-2796.1998.00321.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference